G94E (p.Gly94Glu) variant of SLC6A1 (P30531)
G94E (p.Gly94Glu) in SLC6A1 (P30531) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of not provided; Epilepsy with myoclonic atonic seizures. The available variant effect predictions contribute to a CATVariant prioritization score of 0.92 / 1. The record also includes published literature and structural context.
G94E (p.Gly94Glu) variant details
- p.Gly94Glu
- rs1553688015
- ClinGen CA351788596
- ClinVar RCV000497611
- ClinVar RCV003444558
- Likely pathogenic
- not provided; Epilepsy with myoclonic atonic seizures
- Missense
- Variant Prioritization Score for Impact Estimate 0.917
- AlphaMissense 1.00
- MetaLR 0.89
- MetaSVM 1.07
- PolyPhen-2 1.00
- SIFT 0.00
- EVE 0.89
- ClinVar: Likely pathogenic (not provided; Epilepsy with myoclonic atonic seizures)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Structural context available
- Cited in: SLC6A1 variants identified in epilepsy patients reduce γ-aminobutyric acid transport. (PMID 30132828)
- Cited in: SLC6A1-Related Neurodevelopmental Disorder. (PMID 36780407)